Beyond Medical Technologies Inc
CNSX:DOCT
Cash Flow Statement
Cash Flow Statement
Beyond Medical Technologies Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(7)
|
(5)
|
(7)
|
(7)
|
(6)
|
(6)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
3
|
3
|
4
|
4
|
4
|
4
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Operating Activities |
(3)
N/A
|
(2)
+45%
|
(2)
+3%
|
(2)
-30%
|
(2)
+16%
|
(2)
+10%
|
(1)
+22%
|
(1)
+34%
|
(1)
+19%
|
(1)
-21%
|
(1)
+1%
|
(1)
+15%
|
(1)
-1%
|
(1)
+13%
|
(1)
+25%
|
(0)
+37%
|
(0)
+35%
|
(0)
+55%
|
(0)
+12%
|
(0)
+13%
|
(1)
-756%
|
(1)
-18%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
3
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
|
| Cash from Investing Activities |
2
N/A
|
(0)
N/A
|
(0)
-27%
|
(1)
-221%
|
(1)
+10%
|
(0)
+59%
|
(0)
-52%
|
(0)
+64%
|
0
N/A
|
0
+150%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(2)
N/A
|
(2)
+1%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Cash from Financing Activities |
0
N/A
|
(0)
N/A
|
(0)
-14%
|
3
N/A
|
3
0%
|
3
0%
|
3
+0%
|
(0)
N/A
|
(0)
+5%
|
(0)
-5%
|
0
N/A
|
0
N/A
|
0
+103%
|
0
+65%
|
0
-57%
|
0
+100%
|
0
N/A
|
0
N/A
|
0
-50%
|
0
+551%
|
2
+1 125%
|
4
+86%
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(1)
N/A
|
(2)
-64%
|
(2)
-1%
|
(1)
+76%
|
(0)
+87%
|
1
N/A
|
1
+42%
|
(1)
N/A
|
(1)
+30%
|
(1)
-19%
|
(1)
+10%
|
(1)
+18%
|
(1)
+2%
|
(1)
+17%
|
(0)
+21%
|
(0)
+46%
|
(0)
+43%
|
(0)
+78%
|
(0)
-61%
|
0
N/A
|
0
+20%
|
2
+1 310%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(2)
+55%
|
(2)
-1%
|
(2)
-15%
|
(2)
+4%
|
(2)
+25%
|
(1)
+19%
|
(1)
+34%
|
(1)
+19%
|
(1)
-21%
|
(1)
+1%
|
(1)
+15%
|
(1)
-1%
|
(1)
+13%
|
(1)
+25%
|
(0)
+37%
|
(0)
+35%
|
(0)
+55%
|
(0)
+12%
|
(0)
+13%
|
(1)
-756%
|
(1)
-18%
|
|